Norethindrone Acetate recalls
The FDA has published 3 recalls involving Norethindrone Acetate since 2013. The latest was reported on 20 Jun 2018. Mylan Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2013
Last 12 months0reported
Class I133% of total
Ongoing0latest 20 Jun 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 33%Class II 0 0%Class III 2 67%
Why norethindrone acetate is recalled
Companies
Brands
By year
All norethindrone acetate recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Taytulla Softgel Capsules, 1 mg/20 mcg recalled by Allergan, PLCTaytulla | Allergan, PLC | Other | Nationwide |
| Drug | CLASS III | Norethindrone Acetate and Ethinyl Estradiol Tablets recalledNorethindrone Acetate And Ethinyl Estradiol | Mylan Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS III | Junel(TM) Fe 5/30 (norethindrone acetate recalledJunel | Teva Pharmaceuticals USA | Benzene | Nationwide |
Should you stop taking Norethindrone Acetate?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.